Adjuvant Hormonal Therapy: Improving Medication Adherence
Introduction to Adjuvant Hormonal Therapy Adherence Adjuvant Hormonal Therapy (AHT) represents a critical cornerstone in the management of hormone receptor-positive breast cancer, significantly reducing the risk of recurrence and improving overall survival rates. These treatments, typically prescribed for five to ten years, include selective estrogen receptor modulators (e.g., tamoxifen) and aromatase inhibitors (e.g., anastrozole, letrozole, […]